Security key
640979100
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)
CUSIP: 640979100
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 36,353,167
- Total 13F value
- $512,042,809
- Share change
- +36,353,167
- SEC-reported price per share
- $14.11
- Number of holders
- 38
- Value change
- +$512,042,809
- Number of buys
- 38
- Shares outstanding
- 186,788,806
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
38
Top holders
10
NMRA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Neumora Therapeutics, Inc. SEC filings
Neumora Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640979100
Recent filing periods:
Ownership snapshot
Top reported holders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AMGEN INC
Disclosed value leader
AMGEN INC
Comparable rows
0/2
Latest evidence
19 Sep 2023
3/4/5
Highest disclosed value: $423,716,463
2 rows are not safely comparable across share classes.
Quick read
AMGEN INC has the largest disclosed position value at $423.72M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AMGEN INC's linked filing trail.
Disclosed position value
Top 2
AMGEN INC
$423.72M
FMR LLC
$67.38M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
36,353,167
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q1 2026 Across Filers
Q1 2026 holders
112
Q3 2023 holders
38
Holder diff
-74
| Investor | Q1 2026 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend